1. Catalogs
  2. Network Medical
  3. CORONET™ EndoGlide™ Ultrathin

CORONET™ EndoGlide™ Ultrathin

CORONET™ EndoGlide™ Ultrathin

CORONET™ EndoGlide™ Ultrathin

Product catalog summary
Introduction
The EndoGlide™ Ultrathin DSAEK/DSEK Delivery System is designed for endothelial replacement surgeries, specifically DSAEK, which is becoming the standard due to superior visual acuity results compared to PK. The system is noted for its low published cell loss rates.

Specifications
- Accommodates donor endothelium up to 9.5 mm in diameter and 75µm to 250µm in thickness.
- Patent-protected design that 'coils' the donor tissue to minimize endothelial touch.
- Utilizes a 'pull-through' technique for optimal control.

Features
- Suitable for small eyes, shallow anterior chambers, or high vitreous pressure.
- Transparent cartridge allows for 360˚ visualization.
- Provides 100% control during the procedure.
- Designed to prevent tissue adherence to the device.

Clinical Benefits
The EndoGlide™ Ultrathin has been clinically proven to significantly reduce endothelial cell loss, enhancing long-term outcomes.

Contact Information
Network Medical Products Ltd., Coronet House, Kearsley Road, Ripon, North Yorkshire, HG4 2SG, UK
Tel: +44 1765 609555 | www.networkmedical.co.uk

References
Source: Khor WB, Mehta JS, Tan DT. DSAEK With a Graft Insertion Device: Surgical Technique and Early Clinical Results. Am J Ophthalmol 2011; Vol 151, No. 2: 223-232.
See more

Catalog excerpts

CORONET™ EndoGlide™ Ultrathin-1

EndoGlide™ Ultrathin DSAEK/DSEK Delivery System Lowest Published Cell Lossi

 Open the catalog to page 1
CORONET™ EndoGlide™ Ultrathin-2

CORONET “DSAEK surgery is becoming the golden standard for endothelial replacement, the visual acuity results are outstanding compared to PK and now with the new inserter devices the endothelial cell counts, long term, are proving to be better." The EndoGlide™ Ultrathin has been cNnicaNy proven to dramatically reduces endothelium cell loss. *Source Khor WB, Mehta JS, Tan DT. DSAEK With a Graft Insertion Device: Surgical Technique and Early Clinical Results. Am J Ophthalmol 2011; Vol 151, No. 2: 223232 FIGURE 5. Summary of the mean percentage endothelial cell loss over time for various graft insertion...

 Open the catalog to page 2
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.